These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22166284)

  • 1. Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
    Przybyłowska K; Mrowicki J; Sygut A; Narbutt P; Dziki Ł; Dziki A; Majsterek I
    Pol Przegl Chir; 2011 Feb; 83(2):76-80. PubMed ID: 22166284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
    Falvey JD; Bentley RW; Merriman TR; Hampton MB; Barclay ML; Gearry RB; Roberts RL
    World J Gastroenterol; 2013 Oct; 19(39):6656-64. PubMed ID: 24151396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
    Griga T; Wilkens C; Wirkus N; Epplen J; Schmiegel W; Klein W
    Hepatogastroenterology; 2007; 54(75):784-6. PubMed ID: 17591062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population.
    Mrowicki J; Przybylowska-Sygut K; Dziki L; Sygut A; Chojnacki J; Dziki A; Majsterek I
    Mol Biol Rep; 2014 Jul; 41(7):4639-52. PubMed ID: 24687413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
    Dambacher J; Staudinger T; Seiderer J; Sisic Z; Schnitzler F; Pfennig S; Hofbauer K; Konrad A; Tillack C; Otte JM; Diebold J; Göke B; Ochsenkühn T; Lohse P; Brand S
    Inflamm Bowel Dis; 2007 Jan; 13(1):71-82. PubMed ID: 17206642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
    Zhang H; Ma L; Dong LQ; Shu C; Xu JL
    Gene; 2013 Sep; 526(2):228-31. PubMed ID: 23707797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -2518 A/G MCP-1 polymorphism as a risk factor of inflammatory bowel disease.
    Walczak A; Przybyłowska K; Sygut A; Dziki L; Chojnacki C; Chojnacki J; Dziki A; Majsterek I
    Pol Przegl Chir; 2012 May; 84(5):238-41. PubMed ID: 22763298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population.
    Fei BY; Lv HX; Yang JM; Ye ZY
    Cytokine; 2008 Jan; 41(1):44-7. PubMed ID: 18054247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Effect CAT -262C/T, SOD + 35A/C, GPx1 Pro197Leu Polymorphisms in Patients with IBD in the Polish Population.
    Mrowicki J; Mrowicka M; Majsterek I; Mik M; Dziki A; Dziki Ł
    Pol Przegl Chir; 2016 Dec; 88(6):321-327. PubMed ID: 28141554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.
    Lin Z; Nelson L; Franke A; Poritz L; Li TY; Wu R; Wang Y; MacNeill C; Thomas NJ; Schreiber S; Koltun WA
    J Crohns Colitis; 2010 Jun; 4(2):132-8. PubMed ID: 21122496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis.
    Shen Y; Guo S; Yang T; Jia L; Chen L; An J; Wang T; Wen F
    Int J Mol Sci; 2013 May; 14(6):11392-401. PubMed ID: 23759989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations].
    Shen XY; Shi RH; Wang Y; Zhang HJ; Zhou XQ; Shen FC; Li KB
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1416-20. PubMed ID: 20646633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population.
    Li Y; Yuan T; Lu W; Chen M; Cheng X; Deng S
    Cytokine; 2012 Oct; 60(1):64-7. PubMed ID: 22742858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
    Wang FF; Huang XF; Shen N; Leng L; Bucala R; Chen SL; Lu LJ
    Arthritis Res Ther; 2013; 15(3):R65. PubMed ID: 23721694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
    Jaźwińska-Tarnawska E; Jęśkowiak I; Waszczuk E; Mulak A; Głowacka K; Hurkacz M; Paradowski L; Zaleska Z; Wiela-Hojeńska A
    Pharmacol Rep; 2015 Apr; 67(2):294-8. PubMed ID: 25712653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.
    Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J
    Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
    Huang C; Haritunians T; Okou DT; Cutler DJ; Zwick ME; Taylor KD; Datta LW; Maranville JC; Liu Z; Ellis S; Chopra P; Alexander JS; Baldassano RN; Cross RK; Dassopoulos T; Dhere TA; Duerr RH; Hanson JS; Hou JK; Hussain SZ; Isaacs KL; Kachelries KE; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kumar A; Kwon JH; Lazarev M; Mannon P; Moulton DE; Osuntokun BO; Patel A; Rioux JD; Rotter JI; Saeed S; Scherl EJ; Silverberg MS; Silverman A; Targan SR; Valentine JF; Wang MH; Simpson CL; Bridges SL; Kimberly RP; Rich SS; Cho JH; Rienzo AD; Kao LWH; McGovern DPB; Brant SR; Kugathasan S
    Gastroenterology; 2015 Nov; 149(6):1575-1586. PubMed ID: 26278503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population.
    Kanaan ZM; Eichenberger MR; Ahmad S; Weller C; Roberts H; Pan J; Rai SN; Petras R; Weller EB; Galandiuk S
    J Negat Results Biomed; 2012 Jan; 11():7. PubMed ID: 22269043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.